Navigation Links
Sorrento Announces the Unexpected Death of its Chief Business Officer
Date:7/31/2014

SAN DIEGO, July 31, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) today announced the death of Mr. Amar Singh, Chief Business Officer and Executive Vice President. Mr. Singh died suddenly and unexpectedly of apparent natural causes on July 30.

"Sorrento is deeply saddened and shocked by the loss of our dear friend and colleague. Our immediate thoughts go to Amar's family and friends," said Henry Ji, Ph.D., Sorrento's President and Chief Executive Officer.

Mr. Singh joined Sorrento in January 2014 from Synta Pharmaceuticals, where he served as SVP and Chief Business Officer since December 2010. Previously, Mr. Singh served as: Chief Operating Officer of Spectrum Pharmaceuticals, where he led the commercial and business development teams; VP and Chief Commercial Officer at Novacea responsible for securing partnerships; and Chief Commercial Officer at Abraxis where he led the launch of Abraxane®. Prior to Abraxis, Mr. Singh held multiple commercial leadership positions in the oncology franchise at Hoffman-La Roche for over 10 years. Mr. Singh holds an M.B.A. from the Stern School of Business at New York University and a B.A. from the University of North Carolina at Chapel Hill.

About Sorrento Therapeutics, Inc.
Sorrento is an oncology company developing new treatments for cancer and associated pain. Sorrento's most advanced asset Cynviloq™, the next-generation paclitaxel, commenced its registrational trial in March 2014 and is being developed under the abbreviated 505(b)(2) regulatory pathway. Sorrento is also developing RTX, a non-opiate TRPV1 agonist currently in a Phase 1/2 study at the National Institutes of Health to treat terminal cancer patients suffering from intractable pain. The Company has made signifi
'/>"/>

SOURCE Sorrento Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor
2. Sorrento Therapeutics to Present at the Biotech Showcase 2014 and the 7th Annual OneMed Forum SF2014 in San Francisco
3. Sorrento Therapeutics Completes Acquisition of Concortis Biosystems
4. Sorrento Enters into Definitive Agreement to Acquire Antibody Drug Conjugation Technology
5. Sorrento Therapeutics Adopts Stockholder Rights Plan
6. Sorrento Therapeutics Enters into Antibody and Vaccine Development Alliance for the Prevention and Treatment of Obesity
7. Sorrento Therapeutics Announces Closing of Public Offering of Common Stock
8. Sorrento Therapeutics Announces Pricing of Public Offering of 4,150,000 Shares of Common Stock and Listing on NASDAQ
9. Sorrento Therapeutics Secures Rights to Biomiga Diagnostics Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy
10. Sorrento Therapeutics Completes IgDraSol Merger
11. Sorrento Therapeutics to Present at Two Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Una presentazione speciale durante la settimana ... esperti di MERG valutare i successi ottenuti ... di svariate popolazioni di pazienti affetti dalla patologia. ... Ronnie Fass , MD della Case Western Reserve ... clinici relativi alla terapia Stretta. Un panel di esperti ...
(Date:5/27/2015)... Biosensors International Group, Ltd. ("Biosensors " or the "Company", ... manufacturer and marketer of innovative medical devices, today announced ... and fiscal full year ended 31 March 2015 ("FY15"). ... , Q4 FY15: , Total revenue of US$75.9 ... Year 2014 ("Q4 FY14") due to licensing revenue reduction ...
(Date:5/27/2015)... , May 27, 2015  PDL BioPharma, Inc. (PDL) ... P. McLaughlin , the company,s president and chief executive ... Conference next week in New York City.  The presentation, ... 3, 2015 at 11:30 a.m. EDT. To ... presentation, go to the Company,s website at http://www.pdl.com ...
Breaking Medicine Technology:Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 2Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 3Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG 4Biosensors Reports Financial Results for Fiscal Year 2015 2Biosensors Reports Financial Results for Fiscal Year 2015 3Biosensors Reports Financial Results for Fiscal Year 2015 4Biosensors Reports Financial Results for Fiscal Year 2015 5Biosensors Reports Financial Results for Fiscal Year 2015 6Biosensors Reports Financial Results for Fiscal Year 2015 7PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference 2
... Encouraging 12-Month Outcomes from, Single- Center Study Involving ... 14 OrbusNeich today announced that an,interim analysis ... show good safety and efficacy in the real-world ... Presented by Professor Robbert de Winter, M.D., Ph.D., ...
... study Study needed ... Oct. 13 Advanced Circulatory Systems, Inc.,( http://www.advancedcirculatory.com ) ... in funding from the National Institutes of,Health (NIH) to ... on,those who experience cardiac arrest outside a hospital. Whatcom ...
Cached Medicine Technology:Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 2Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 3Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2
(Date:5/27/2015)... The news is full of companies getting ... documentation or appropriate training: an automobile manufacturer, a store ... company in Texas and the list goes on. The ... due to improper training and documentation (Osha.gov). eLeaP ... the new Supervisor feature which provides a powerful tool ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Danish scientists ... line” biomarkers that have the potential to help in ... to read the full story that has just ... University in Aalborg, Denmark say new biomarkers found in ... outlook for patients with malignant mesothelioma . ...
(Date:5/27/2015)... The Society for Women's Health Research ... research on sex differences in health and disease, today ... advocates, organizations, and celebrities in bringing awareness to the ... campaign features a short film that shares the stories ... as a result of their abuse, as well as ...
(Date:5/27/2015)... May 27, 2015 National ... partner, award winning web development and interactive ... announce the launch of its newly redesigned, ... , National Healthcare Providers, is a physician ... in the areas of Radiology, Anesthesiology, Emergency ...
(Date:5/27/2015)... silver spring, MD (PRWEB) May 27, 2015 ... Company in USA, helped its client to launch an ... Payment app allows merchants to accept credit, debit and ... be downloaded from Google Play at: https://play.google.com/store/apps/details?id=com.simpalm.paymentgateway . ... Jan 2013 and has been recently updated by SIMpalm. ...
Breaking Medicine News(10 mins):Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 2Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 3Health News:New Report Highlights Current and Emerging Biomarkers for Mesothelioma, According to Surviving Mesothelioma 2Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 2Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 3Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 2Health News:National Healthcare Providers Showcases Expanded Business Model with Launch of New Website 3Health News:Forte Payment System Launches Android Version of Payment App 2
... CARLSBAD, Calif., Oct. 2 Isis,Pharmaceuticals, Inc. (Nasdaq: ... received,clearance under the Hart-Scott-Rodino Antitrust Improvements Act for ... company, which,was announced on September 13, 2007. ... to Ortho-McNeil,worldwide development and commercialization rights to two ...
... for a loved one with dementia, TUCSON, Ariz., ... a new book that aims to ease the challenges ... and,Families are Still Asking WHY?, author Jim Greenwood, whose ... and useful,advice on how to best care for a ...
... Recruitment Efforts for Pulmonary Study, SOLANA ... Solutions, LLC, a firm specializing in patient ... its team of Regional Recruitment,Specialists(TM) in support ... of,Chronic Obstructive Pulmonary Disease (COPD) for a ...
... for Massachusetts Firms, WASHINGTON, Oct. 1 ... bill with provisions secured by,Senator John Kerry (D-Mass.) ... through 2010 and to increase the transition and,commercialization ... will ensure that the thousands of firms that ...
... Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) announced ... (FDA) has approved the SymlinPen(TM) 120 and ... acetate) injection. These new pre-filled pen-injector devices,feature ... control. "SymlinPen 120 and SymlinPen 60 ...
... any period of time after leaving the foster care ... than those with stable housing situations, according to a ... & Adolescent Medicine, one of the JAMA/Archives journals. Youth ... after leaving the foster care system appear to have ...
Cached Medicine News:Health News:Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc. 2Health News:Alzheimer's Caregivers Get Sage Advice 2Health News:RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM) 2Health News:Kerry Extends, Improves Small Business Innovation Program 2Health News:FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use 2Health News:FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use 3Health News:FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use 4Health News:Poor health care access common among youth leaving foster system 2Health News:Poor health care access common among youth leaving foster system 3
... Sysmex UF-50 is designed to bring efficiency ... It combines the superior technology of ... sample analysis. Continuous sampling or batch ... autosamplers, streamlining sample processing in high volume ...
... The iQ200 System incorporates the ... and the AUTION MAX™ AX-4280 Automated ... a fully integrated chemical and microscopic ... (APR™), a well trained neural network, ...
... The Sysmex UF-100 is designed to bring ... analysis. It combines the superior technology ... urine sample analysis. Continuous sampling or ... rack-based autosamplers, streamlining sample processing in high ...
... easy to use Ambulatory Urodynamic recorder which ... practising urologists as an invaluable aid in ... The system offers the possibility to measure ... natural bladder filling, extented over a longer ...
Medicine Products: